European Archives - Page 964 of 981 - European Medical Journal

EMJ

Prostate Cancer: A State of The Heart

This symposium was focused on reviewing androgen deprivation therapy (ADT) in prostate cancer, highlighting the implications of this therapy in clinical…

EMJ

Glycosaminoglycan-Replenishment Therapy: Rationale For Use and Current Evidence

The glycosaminoglycan (GAG) layer of the bladder represents a mucous layer on the surface of the urothelium. Acting as an antibacterial defence mechanism…

EMJ

Innovative Approaches in Urological Cancers

With approximately 150,000 new cases of bladder cancer diagnosed each year, and two-thirds of these being non-muscle invasive bladder cancer (NMIBC)…

EMJ

The Many Faces Of mCRPC- Assessing Patient Profiles and Tailoring Treatment in a Changing Landscape

Prof Fred Saad began his presentation by introducing the audience to the different prostate cancer disease states. These range from patients with…

EMJ Urology 2014

A comprehensive review of the 2014 European Association Congress that took place in Stockholm, Sweden

Acute Liver Failure: Pathophysiologic Basis, and The Current and Emerging Therapies

Acute liver failure (ALF) is a devastating condition that occurs in patients who previously had a normal liver. Although the outcome of patients with ALF…

Acute Liver Failure: A Dangerous and Challenging Syndrome

Despite progress in understanding the underlying mechanisms, acute liver failure (ALF) is still one of the major clinical challenges in hepatology.

EMJ

New Way to Treat HER2-Positive Breast Cancer

Scientists at Cold Spring Harbor Laboratory (CSHL) have reported a discovery that they hope will lead to the development of a powerful new way of…

Liver Transplantation For Alcoholic Liver Disease – Time for a Paradigm Shift?

Liver transplantation for alcoholic liver disease (ALD) is controversially discussed. Although overall survival after liver transplantation is similar to…

Use of HBSAG Quantification To Guide HBIG Prophylaxis After Liver Transplantation

Hepatitis B surface antigen (HBsAg) quantification has recently been introduced to guide treatment in chronic hepatitis B virus (HBV) patients.